Search Within

Sujata Patil

  1. "Advanced Practice Providers"
Formats
  1. Meeting Abstract (19)
  2. Journal Article (12)
Groups
  1. Advanced Practice Providers (31)
  2. Biostatistics Service (31)
  3. Epidemiology and Biostatistics (31)
  4. Surgery (30)
  5. Survivorship Research (27)
  6. Nursing (25)

More Groups

People
  1. Darren Feldman (12)
  2. George Bosl (12)
  3. Jessica Goldberg (12)
  4. Kimberly Van Zee (12)
  5. Robert Motzer (12)
  6. Joel Sheinfeld (11)

More People

Years
  1. 2021 (1)
  2. 2020 (1)
  3. 2018 (1)
  4. 2016 (1)
  5. 2015 (3)
  6. 2014 (2)

More Years

Publications
  1. Journal of Clinical Oncology (15)
  2. Annals of Surgical Oncology (6)
  3. Cancer (2)
  4. Cancer Research (2)
  5. Annals of Surgery (1)
  6. Biology of Blood and Marrow Transplantation (1)

More Publications

Publishers
  1. American Society of Clinical Oncology (15)
  2. Springer (8)
  3. American Association for Cancer Research (2)
  4. Elsevier Inc. (2)
  5. Wiley Blackwell (2)
  6. Lippincott Williams & Wilkins (1)

More Publishers

Results (31)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase I/II study of paclitaxel plus ifosfamide (TI) followed by high-dose paclitaxel, ifosfamide, and carboplatin (TIC) with autologous stem cell transplant (ASCT) for salvage treatment of germ cell tumors (GCT)
    Meeting Abstract

    Jia, X.; Feldman, D. R.; Glezerman, I.; Van Alstine, L. J.; Bajorin, D. F.; Fischer, P.; Hughes, A.; Sheinfeld, J.; Bains, M. S.; Reich, L.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Paclitaxel, ifosfamide, and cisplatin (TIP) efficacy for first-line treatment of patients (pts) with intermediate- or poor-risk germ cell tumors (GCT)
    Meeting Abstract

    Feldman, D. R.; Hu, J.; Dorff, T. B.; Patil, S.; Van Alstine, L. J.; Momen, L.; Carousso, M.; Hughes, A.; Snively-Solomon, J.; Ketchens, C.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Is there a role for routine screening MRI in women with LCIS?
    Journal Article

    King, T. A.; Muhsen, S.; Patil, S.; Koslow, S.; Oskar, S.; Park, A.; Morrogh, M.; Sakr, R. A.; Morrow, M.
    Breast Cancer Research and Treatment (2013)

    Fulltext@MSK | Save
  • Limited absorption of low dose 10µg intravaginal 17-β Estradiol (Vagifem®) in postmenopausal women with breast cancer on aromatase inhibitors
    Meeting Abstract

    Goldfarb, S. B.; Dickler, M.; Dnistrian, A.; Patil, S.; Dunn, L.; Chang, K.; Berkowitz, A.; Tucker, N.; Carter, J.; Barakat, R.; more...
    Cancer Research (2012)

    Fulltext@MSK | Save
  • Common breast cancer risk alleles and lobular carcinoma in situ (LCIS)
    Meeting Abstract

    Koslow, S.; Manschreck, C.; Patil, S.; Vijai, J.; Muhsen, S.; Park, A.; Robson, M.; King, T.
    Annals of Surgical Oncology (2012)

    Fulltext@MSK | Save
  • Blurry boundaries: 'Borderline' lesions and DCIS of the lreast
    Meeting Abstract

    Choi, D. X.; Patil, S.; Eaton, A. A.; Goldberg, J.; Morrow, M.; Van Zee, K. J.
    Annals of Surgical Oncology (2012)

    Fulltext@MSK | Save
  • Progression-free and overall survival in patients with relapsed/refractory germ cell tumors treated with single-agent chemotherapy: Endpoints for clinical trial design
    Journal Article

    Feldman, D. R.; Patil, S.; Trinos, M. J.; Carousso, M.; Ginsberg, M. S.; Sheinfeld, J.; Bajorin, D. F.; Bosl, G. J.; Motzer, R. J.
    Cancer (2012)

    Fulltext@MSK | Save
  • Patient characteristics associated with the decision to undergo bilateral prophylactic mastectomy for lobular carcinoma in situ
    Meeting Abstract

    Muhsen, S.; Junqueira, M. J.; Park, A.; Sung, J. S.; Patil, S.; Oskar, S.; Morrogh, M.; Morrow, M.; King, T. A.
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Breast conservation (BCT) for DCIS: A prospective study of how MRI impacts management (MGMT)
    Meeting Abstract

    Marti, J. L.; Goldberg, J. I.; Patil, S.; Barbashina, V. V.; Giri, D. D.; Brennan, S.; Lee, C.; Vallejo, C.; Morris, E. A.; Van Zee, K. J.
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save
  • Progression-free survival (PFS) as a new endpoint for designing phase II trials in patients with refractory germ cell tumors (GCT)
    Meeting Abstract

    Feldman, D. R.; Patil, S.; Trinos, M. J.; Carousso, M.; Ginsberg, M. S.; Sheinfeld, J.; Bajorin, D. F.; Bosl, G. J.; Motzer, R. J.
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save